Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
about
Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesisAssociations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutationsCancer biomarker discovery: the entropic hallmark.Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based studyCell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).Rapid progression of prostate cancer in men with a BRCA2 mutation.Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate TumorsThe role of the BRCA2 gene in susceptibility to prostate cancer revisitedGermline BRCA mutations denote a clinicopathologic subset of prostate cancer.The role of BRCA1 and BRCA2 in prostate cancer.A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility.Markers for detection of prostate cancer.Familial association of pancreatic cancer with other malignancies in Swedish families.Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.Prostate cancer: germline prediction for a commonly variable malignancy.Nucleic acid-based tissue biomarkers of urologic malignancies.Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.Genetic variants associated with predisposition to prostate cancer and potential clinical implications.P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.Germline BRCA mutation in male carriers-ripe for precision oncology?Male Oncology Research and Education program for men at high risk for prostate cancer.
P2860
Q27347240-1F02BF6C-9893-4CD0-B3E6-86E7D4F9C471Q28386233-F236C15A-B15C-4C5E-91C9-FBE336FF5361Q30496149-B38C6B24-8091-478E-8B1B-BCB2DD3DFF93Q33609681-77BC70C6-1175-4A63-84F7-0898313BE268Q33741652-9BFB02F6-126F-48D0-8CBC-1F84B9D8ABEBQ34168304-0E4D919B-1451-49FF-94B5-E5AE2B5FE204Q34838226-DCAEC94A-99C1-46D8-A0B9-99D4D2FBB5A0Q35687887-CE30ADDF-1F3D-40C6-A737-4737588170AAQ36110947-56666130-6845-4EA7-97B0-5448E4153171Q36118895-04F0F90D-8FDF-4147-936F-2230A46B74F7Q36503369-14512A3F-D2F8-4267-8260-B5172F8C4C14Q36785963-58DB6745-D3AD-4107-913B-871C9E89C6F3Q36818918-B10AD76B-9816-4590-BB6C-41729FC30BD4Q36891144-94147BA4-A190-478C-A147-E0E8D15A5144Q36924831-2BBB2ADE-2AE1-4049-BA42-319C606AB9DFQ37019841-8838D704-045D-4529-A919-64395DBD8877Q37037789-10B362B5-1C10-438A-9B7E-F251C09CD47EQ37081107-C6428C44-2304-4E7F-A651-04AC1626321CQ37161398-1673730F-C7EE-4B25-A6D3-986FA75366CDQ37328403-5FC93FFA-A888-4F4A-B365-FB5D5916972EQ37424060-2DABE166-767E-44E5-AA7D-9363903B0A76Q37481918-2FB3A38D-D208-41F6-96AB-CF988DA056CDQ37632049-FE06A051-AEB4-4970-B4B7-C6062E530F00Q37650650-25CF913E-DFF8-49D1-861A-B49DC28CE567Q38043095-75C93301-D2D5-4008-8467-43B4D99F544AQ38216131-4D1FF1AA-449C-4034-82EB-8BB0BECB9A1DQ38893354-8E6241D7-C91C-4978-85BA-A873F87C3354Q39141778-088CCE6D-DA78-4782-956C-9B9A4C69800FQ39199102-F3F5F2E8-7A77-4B34-85E3-B1B4BF1E69DCQ40625913-4BB0295B-D7FA-439B-916B-81C04A2996DCQ43415543-C10BD0A3-05A2-4960-A5A4-9CC71917F5F9Q44013374-C9C1E35B-606D-46DB-B13C-D76DD5646C4DQ46083971-CA7DB8E0-2615-47F8-B9B3-B8E7126E6E57Q46798905-64C25C81-4AE4-48B7-9D60-AB5A160F4FBEQ55249860-A81B814D-C95E-4B6E-B340-52E08822DE87
P2860
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Rare germline mutations in the ...... h early-onset prostate cancer.
@ast
Rare germline mutations in the ...... h early-onset prostate cancer.
@en
type
label
Rare germline mutations in the ...... h early-onset prostate cancer.
@ast
Rare germline mutations in the ...... h early-onset prostate cancer.
@en
prefLabel
Rare germline mutations in the ...... h early-onset prostate cancer.
@ast
Rare germline mutations in the ...... h early-onset prostate cancer.
@en
P2093
P2860
P356
P1476
Rare germline mutations in the ...... h early-onset prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603929
P407
P577
2007-08-14T00:00:00Z